<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        69-19-13
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DAIVOBET GEL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BETAMETHASONE DIPROPIONATE,Calcipotriol
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        µg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gel
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tube
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        148.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Leo Laboratories Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Leo Laboratories Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Leo Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D05AX52
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Daivobet is used as topical treatment of scalp psoriasis in adults and on the skin of other body areas to treat mild to moderate plaque psoriasis (psoriasis<br />vulgaris) in adults. Psoriasis is caused by your skin cells being produced too<br />quickly. This causes redness, scaling and thickness of your skin.<br />Daivobet contains calcipotriol and betamethasone. Calcipotriol helps to bring the rate of skin cell growth back to normal and betamethasone acts to<br />reduce inflammation.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Daivobet:</strong></p><p>&bull; if you are allergic (hypersensitive) to calcipotriol, betamethasone or any of<br />the other ingredients of this medicine (listed in section 6)<br />&bull; if you have problems with calcium levels in your body (ask your doctor)<br />&bull; if you have certain types of psoriasis: these are erythrodermic, exfoliative<br />and pustular (ask your doctor).<br />As Daivobet contains a strong steroid, do NOT use it on skin affected by:<br />&bull; skin infections caused by viruses (e.g. cold sores or chicken pox)<br />&bull; skin infections caused by a fungus (e.g. athlete&rsquo;s foot or ringworm)<br />&bull; skin infections caused by bacteria<br />&bull; skin infections caused by parasites (e.g. scabies)<br />&bull; tuberculosis (TB) &bull; perioral dermatitis (red rash around the mouth)<br />&bull; thin skin, easily damaged veins, stretch marks<br />&bull; ichthyosis (dry skin with fish-like scales)<br />&bull; acne (pimples)<br />&bull; rosacea (severe flushing or redness of the skin on the face)<br />&bull; ulcers or broken skin.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor/nurse/pharmacist before and during use of Daivobet if:<br />&bull; you are using other medicines that contain corticosteroids as you may get side effects<br />&bull; you have used this medicine for a long time and plan to stop (as there is a risk your psoriasis will get worse or &lsquo;flare up&rsquo; when steroids are stopped<br />suddenly)<br />&bull; you have diabetes mellitus (diabetes) as your blood sugar/glucose level may be affected by the steroid<br />&bull; your skin becomes infected as you may need to stop your treatment<br />&bull; you have a certain type of psoriasis called guttate psoriasis<br />&bull; you experience blurred vision or other visual disturbances.</p><p><u><strong>Special precautions</strong></u></p><p>Avoid use on more than 30% of your body or using more than 15grams per day<br />&bull; Avoid using under a bathing cap, bandages or dressings as it increases the absorption of the steroid<br />&bull; Avoid use on large areas of damaged skin, on mucous membranes, or in skin folds (groin, armpits, under breasts) as it increases the absorption of<br />the steroid<br />&bull; Avoid use on your face or genitals (sex organs) as they are very sensitive to steroids<br />&bull; Avoid excessive sunbathing, excessive use of solarium and other forms of light treatment.<br />Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.<br /><strong>Children</strong><br />Daivobet is not recommended for the use in children below the age of 18years.<br />Other medicines and Daivobet<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p><strong>Other medicines and Daivobet</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br /><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this<br />medicine. If your doctor has agreed that you can breast-feed, take care and<br />do not apply Daivobet to the breast area.<br /><strong>Driving and using machines</strong><br />This medicine should not have any effect on your ability to drive or use<br />machines.<br /><strong>Daivobet contains butylated hydroxytoluene (E321)</strong><br />Daivobet contains butylated hydroxytoluene (E321), which may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous<br />membranes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with<br />your doctor or pharmacist if you are not sure.<br />How to put on Daivobet: Cutaneous use.<br /><u>Instructions for proper use</u><br />&bull; Use only on your psoriasis and do not use on skin which does not have psoriasis<br />&bull; Shake the bottle before use and remove the cap<br />&bull; Squeeze the gel onto a clean finger or directly onto the area affected by psoriasis<br />&bull; Apply Daivobet to the affected area with your fingertips, and rub it in gently until the area affected by psoriasis is covered by a thin layer of gel<br />&bull; Do not bandage, tightly cover or wrap the treated skin area<br />&bull; Wash your hands well after using Daivobet. This will avoid accidentally spreading the gel to other parts of your body (especially the face, mouth<br />and eyes)<br />&bull; Do not worry if some gel accidentally gets on normal skin near your psoriasis, but wipe it off if it spreads too far<br />&bull; In order to achieve optimal effect, it is recommended not to take a shower or bath immediately after application of Daivobet gel<br />&bull; After applying the gel, avoid contact with textiles which are easily stained by grease (e.g. silk).<br /><u>If you have scalp psoriasis</u><br />&bull; Before applying Daivobet to the scalp, comb the hair to remove any loose scales. Tilt your head to make sure Daivobet does not run onto your face. It may help to part your hair before you use Daivobet. Apply Daivobet to the affected area with your fingertips, and rub it in gently.<br /><strong>Washing your hair before application of Daivobet is not necessary.</strong></p><p>&nbsp;</p><p><img alt="" width="333" height="240" src="data:image/png;base64,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" /></p><p><strong>In order to achieve optimal effect, it is recommended that the hair is<br />not washed immediately after application of Daivobet.<br />Let Daivobet remain on the scalp during the night or during the day.<br />When washing hair after application the following instructions might<br />be useful:</strong></p><p><img alt="" width="336" height="190" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p><strong>If necessary, repeat steps 4-6 once or twice.</strong></p><p><strong><u>Duration of treatment</u></strong></p><p><strong>&bull; Use the gel once a day. It may be more convenient to use the gel in the evening<br />&bull; The normal initial treatment period is 4weeks for scalp areas and 8weeks for non-scalp areas<br />&bull; Your doctor may decide on a different treatment period<br />&bull; Your doctor may decide on repeated treatment<br />&bull; Do not use more than 15grams in one day.<br />If you use other calcipotriol containing medicines, the total amount of<br />calcipotriol medicines must not exceed 15grams per day and the area treated should not exceed 30% of the total body surface.</strong></p><p>&nbsp;</p><p><strong>What should I expect when I use Daivobet?</strong></p><p>Most patients see obvious results after 2weeks, even if the psoriasis is not yet cleared at that point.</p><p>&nbsp;</p><p><strong>If you use more Daivobet than you should</strong></p><p><strong>Contact your doctor if you have used more than 15grams in one day.<br />Excessive use of Daivobet may also cause a problem with calcium in your blood, which usually normalises when discontinuing treatment.<br />Your doctor may need to carry out blood tests to check that using too much gel has not caused a problem with calcium in your blood.<br />Excessive prolonged use can also cause your adrenal glands to stop working<br />properly (the adrenal glands are found near the kidneys and produce<br />hormones).</strong></p><p>&nbsp;</p><p><strong>If you forget to use Daivobet</strong><br />Do not take a double dose to make up for a forgotten dose.<br /><strong>If you stop using Daivobet</strong><br />The use of Daivobet should be stopped as indicated by your doctor. It may be necessary for you to stop this medicine gradually, especially if you have<br /><strong>used it for a long time.</strong><br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not<br />everybody gets them.<br />Serious side effects<br />Tell your doctor/nurse immediately or as soon as possible if any of the<br />following happens. You may have to stop your treatment.<br />The following serious side effects have been reported for Daivobet:<br />Uncommon (may affect up to 1in 100people):<br />&bull; Worsening of your psoriasis. If your psoriasis gets worse, tell your doctor<br />as soon as possible.<br />Some serious side effects are known to be caused by betamethasone (a<br />strong steroid), one of the ingredients in Daivobet. You should tell your doctor as soon as possible if any of the serious side effects occur. These side effects are more likely to happen after long-term use, use in skin folds (e.g.<br />groin, armpits or under breasts), use under occlusion, or use on large areas<br />of skin.<br />The side effects include the following:<br />&bull; Your adrenal glands may stop working properly. Signs are tiredness, depression and anxiety<br />&bull; Cataracts (signs are cloudy and foggy vision, difficulty seeing at night and sensitivity to light) or an increase in pressure inside the eye (signs are eye<br />pain, red eye, decreased or cloudy vision)<br />&bull; Infections (because your immune system, which fights infections, may be suppressed or weakened)<br />&bull; Pustular psoriasis (a red area with yellowish pustules usually on the hands or feet). If you notice this, stop using Daivobet and tell your doctor as soon as possible<br />&bull; Impact on the metabolic control of diabetes mellitus (if you have diabetes you may experience fluctuations in the blood glucose levels).<br />Serious side effects known to be caused by calcipotriol:<br />&bull; Allergic reactions with deep swelling of the face or other parts of the body such as the hands or feet. Swelling of the mouth/throat and trouble<br />breathing may occur. If you have an allergic reaction, stop using Daivobet, tell your doctor immediately or go to the casualty department at your nearest hospital<br />&bull; Treatment with this gel may cause the level of calcium in your blood or&nbsp;urine to increase (usually when too much gel has been used). Signs of<br />increased calcium in blood are excessive secretion of urine, constipation,<br />muscle weakness, confusion and coma. <strong>This can be serious, and you<br />should contact your doctor immediately</strong>. However, when the treatment<br />is stopped, the levels return to normal.</p><p><strong>Less serious side effects</strong><br />The following less serious side effects have been reported for Daivobet.<br />Common side effects (may affect up to 1in 10 people):<br />&bull; Itching.<br />Uncommon (may affect up to 1in 100people):<br />&bull; Eye irritation<br />&bull; Burning sensation of the skin<br />&bull; Skin pain or irritation<br />&bull; Inflammation or swelling of the hair root (folliculitis)<br />&bull; Rash with inflammation of the skin (dermatitis)<br />&bull; Redness of the skin due to widening of the small blood vessels (erythema)<br />&bull; Acne (pimples)<br />&bull; Dry skin<br />&bull; Rash<br />&bull; Pustular rash<br />&bull; Infection of the skin.<br />Rare (may affect up to 1in 1,000people):<br />&bull; Allergic reactions<br />&bull; Stretch marks<br />&bull; Skin exfoliation<br />&bull; Rebound effect: A worsening of symptoms/psoriasis after ended treatment.<br />Frequency not known (frequency cannot be estimated from the<br />available data):<br />&bull; White or grey hair can transiently change to a yellowish colour at the application site when used on the scalp<br />&bull; Blurred vision.<br />Less serious side effects caused by using betamethasone, especially for<br />a long time, include the following. You should tell your doctor or nurse as<br />soon as possible if you notice any of them:<br />&bull; Thinning of the skin<br />&bull; Appearance of surface veins or stretch marks<br />&bull; Changes in hair growth<br />&bull; Red rash around the mouth (perioral dermatitis)<br />&bull; Skin rash with inflammation or swelling (allergic contact dermatitis)<br />&bull; Golden coloured gel-filled bumps (colloid milia)<br />&bull; Lightening of skin colour (depigmentation)<br />&bull; Inflammation or swelling of the hair root (folliculitis).<br />Less serious side effects known to be caused by calcipotriol include the<br />following:<br />&bull; Dry skin<br />&bull; Sensitivity of the skin to light resulting in a rash<br />&bull; Eczema<br />&bull; Itching<br />&bull; Skin irritation<br />&bull; Burning and stinging sensation<br />&bull; Redness of the skin due to widening of the small blood vessels (erythema)<br />&bull; Rash<br />&bull; Rash with inflammation of the skin (dermatitis)<br />&bull; Worsening of psoriasis.<br />Reporting of side effects<br />If you get any side effects, talk to your doctor, pharmacist or nurse. This<br />includes any possible side effects not listed in this leaflet.<br />By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep this medicine out of the sight and reach of children<br />&bull; Do not use this medicine after the expiry date, which is stated on the<br />bottle after EXP. The expiry date refers to the last day of that month<br />&bull; Do not refrigerate. Keep the bottle in the outer carton in order to protect from light<br />&bull; Discard the bottle with any remaining gel 3months after first opening.<br />Do not throw away any medicines via wastewater or household waste. Ask<br />your pharmacist how to throw away medicines&nbsp;you no longer use. These<br />measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are:<br />Calcipotriol and betamethasone.<br />One gram of gel contains 50micrograms of calcipotriol (as monohydrate) and 0.5mg of betamethasone (as dipropionate).<br />The other ingredients are:<br />&bull; paraffin, liquid<br />&bull; polyoxypropylene stearyl ether<br />&bull; castor oil, hydrogenated<br />&bull; butylhydroxytoluene (E321)<br />&bull; all-rac-&alpha;-tocopherol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Daivobet is an almost clear, colourless to slightly off-white gel filled in high-
density polyethylene bottles with a low-density polyethylene nozzle and a high-density polyethylene screw cap. The bottles are placed in cartons.
Pack sizes: 30g & 60g. Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorisation holder is:<br />LEO Pharma A/S, Industriparken 55, DK-2750Ballerup, Denmark<br />The manufacturer is:<br />LEO Laboratories Ltd., 285 Cashel Road, Crumlin, Dublin 12, Ireland</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2020.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">علاج موضعي لمرض صدفية فروة الرأس لدى البالغين وعلى &reg; يستعمل دايڤوبيت<br />جلد مناطق أخرى من الجسم لعلاج حالات خفيفة إلى معتدلة من الصداف اللويحي<br />)الصدفية الشائعة( لدى البالغين. تحدث الصدفية بسبب إنتاج خلايا الجلد بسرعة<br />كبيرة. وينتج عن الإصابة بالصدفية احمرار الجلد وتقشره وزيادة سماكته.<br />يحتوي دايڤوبيت على كالسيبوتريول بيتاميثازون يساعد الكالسيبوتريول على إعادة<br />معدل نمو خلايا الجلد إلى طبيعته ويعمل بيتاميثازون على تقليل الالتهاب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-indent:50px">&nbsp;لا تستخدم دايڤوبيت&reg; إ<br />&bull; كنت تشكو من حساسية )إفراط في الحساسية( لكالسيبوتريول أو بيتاميثازون أو<br />&nbsp;أي من مكونات الدواء الأخرى (المدرجة في القسم 6).<br />&bull; كان لديك مشاكل مع مستويات الكالسيوم في الجسم (اسأل طبيبك)<br />&bull; كنت تعاني من أنواع معينة من الصدفية<br />وهذه الأنواع هي الأحمرية، التقشري والبثري (اسأل طبيبك).<br />يحتوي على ستيرويد قوي، فإن استعماله محظور على الجلد المصاب &reg; لأن دايڤوبيت<br />بما يلي:<br />&bull; الأمراض الجلدية التي تسببها الفيروسات (مثل القروح الباردة أو جدري الماء).<br />&bull; الالتهابات التي يسببها نوع من الفطريات (مثل القدم الرياضي أو السعفة).<br />&bull; الأمراض الجلدية التي تسببها البكتيريا<br />&bull; الأمراض الجلدية التي تسببها الطفيليات (مثل الجرب)<br />&bull; التدرن مرض السل<br />&bull; التهاب الجلد المحيط بالفم (طفح جلدي أحمر حول الفم)<br />&bull; رقة الجلد، والأوردة السهلة التلف، والتجعدات الصغيرة<br />&bull; السُماك (جفاف الجلد وظهور قشور عليه تشبه قشور السمك).<br />&bull; حب الشباب (البثور)<br />&bull; العُدُّ الوردي (احمرار أو تورُّد شديد في جلد الوجه)<br />&bull; تقرحات أو جلد مجروح.<br />تحذيرات واحتياطات<br />قبل استعمال هذا الدواء، أخبر طبيبك/ ممرضتك/ الصيدلاني إذا:<br />&bull; كنت تستعمل أدوية أخرى تحتوي على ستيرويدات قشرية، بسبب احتمال حصول<br />آثار جانبية.<br />&bull; كنت قد استعملت هذا الدواء لفترة طويلة، وتفكر بإيقافه )فهناك خطورة في أن<br />الصدفية ستتفاقم على نحو أسوأ أو &quot;تشتعل&quot; عندما يتم إيقاف الستيرويدات فجأة(<br />&bull; كنت مصابًا بسكري البول (السكري)، إذ قد يتأثر مستوى السكر في الدم/الجلوكوز<br />بالستيرويد<br />&bull; أُصيب جلدك بالعدوى، إذ قد تحتاج إلى وقف العلاج.<br />&bull; إذا كنت مصابًا بنوع معين من الصدفية يسمى الصدفية النقطية<br />&bull; إذا كنت تعاني من تشوش الرؤية أو اضطرابات بصرية أخرى.<br />احتياطات خاصة<br />&bull; تجنب الاستعمال على أكثر من 30 % من جسمك أو استعمال أكثر من<br />15 جراماً يومياً<br />&bull; تجنب استعماله تحت غطاء الرأس والضمادات أو الضمادات المغلقة لأن هذا من<br />شأنه أن يزيد من امتصاص الستيوريدات<br />&bull; تجنب استخدام هذا الدواء على مناطق كبيرة من الجلد المصاب أو على الأغشية<br />المخاطية أو بين ثنايا الجلد (على الفخذين أو تحت الإبطين أو تحت الثديين)&nbsp;لأن<br />هذا يزيد من امتصاص الستيرويدات<br />&bull; تجنب استخدام هذا الدواء على الوجه أو الأعضاء التناسلية لأنها حساسة<br />للغاية للستيرويدات<br />&bull; تجنب حمامات الشمس المفرطة ، والاستخدام المفرط للاستلقاء تحت أشعة الشمس<br />وأشكال أخرى من العلاج بالضوء.<br />لا تدخن أو تقترب من اللهب المكشوف - لتجنب خطر التعرض لحروق شديدة.<br />يحترق النسيج(الملابس، الفراش، الضمادات، إلخ)&nbsp;الذي يلامس هذا المنتج بسهولة<br />أكبر ويشكل خطرًا كبيرًا لحدوث حريق. قد يقلل غسل الملابس وأغطية الأسرة من<br />تراكم المنتج ولكن لا يزيله تمامًا.<br />الأطفال<br />لدى الأطفال الذين تقل أعمارهم عن 18 سنة. &reg; لا ينصح باستعمال دايڤوبيت<br />&reg; الأدوية الأخرى ودايڤوبيت<br />أخبر طبيبك أو الصيدلي إذا كنت تتناول أدوية أخرى أو تناولت أي أدوية أخرى<br />مؤخرًا أو قد تتناول أدوية أخرى.<br />الحمل والرضاعة الطبيعية<br />إذا كنتِ حاملاً أو ترضعين رضاعة طبيعية أو تعتقدين أنكِ حامل أو تخططين<br />للإنجاب، يجب استشارة الطبيب قبل استخدام هذا الدواء. فإذا رأى الطبيب أنه يمكنكِ<br />على منطقة الثدي. &reg; الرضاعة الطبيعية، فيُرجى الحذر وعدم وضع دايڤوبيت<br />القيادة واستخدام الآلات<br />لا يوجد لهذا الدواء أي تأثير على قدرتك على القيادة أو استخدام الآلات.<br />( على بيوتيليتيد هيدروزيتولوين )إي 321 &reg; يحتوي دايڤوبيت<br />على بيوتيليتيد هيدروزيتولوين )إي 321 (، والذي قد &reg; يحتوي دايڤوبيت<br />يسبب ردود فعل جلدية موضعية (مثل التهاب الجلد التماسي)، أو تهيج العيون<br />والأغشية المخاطية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم هذا الدواء دائمًا وفقًا لتعليمات الطبيب. استشر طبيبك أو الصيدلي في حالة<br />عدم التأكد بشأن طريقة الاستعمال.<br />استعمال موضعي علي الجلد :&reg; كيفية وضع دايڤوبيت<br /><u>تعليمات للاستعمال الصحيح</u><br />&bull; استخدم هذا الدواء على الجلد المصاب بالصدفية فقط، ولا تستخدمه على الجلد<br />غير المصاب.<br />&bull; رج القنينة قبل الاستعمال وإزالة الغطاء<br />&bull; اضغط الهلام (الجل)&nbsp;على إصبع نظيفة أو مباشرة على المنطقة المصابة بالصدفية<br />على المنطقة المصابة بأطراف أصابعك، وفرك بلطف حتى تغطي &reg; &bull; ضع دايڤوبيت<br />المنطقة المصابة بالصدفية بطبقة رقيقة من الهلام<br />&bull; لا تضمد أو تغطي أو تلف منطقة الجلد المعالَجة بإحكام<br />فهذا من شأنه أن يمنع انتشار الهلام عن .&reg; &bull; اغسل يديك جيدًا بعد استعمال دايڤوبيت<br />طريق الخطأ إلى أجزاء أخرى من الجسم (وخاصةً الوجه والفم والعينين)<br />&bull; لا تقلق إذا وضعت بعض الهلام عن طريق الخطأ على جلدك السليم بالقرب من<br />جلدك المصاب بالصدفية، ولكن امسح هذا الهلام إذا انتشر كثيرًا<br />&bull; من أجل تحقيق تأثير مثالي، من المستحسن، عدم الاستحمام أو الاستحمام مباشرةً<br />&reg; بعد استعمال هلام دايڤوبيت<br />&bull; بعد وضع الهلام على الجلد، تجنب ملامسة المنسوجات التي تتسخ بسهولة بالشحوم<br />(مثل الحرير).<br />إذا كنت مصاباً بصدفية فروة الرأس<br />على فروة الرأس، مشط شعرك لإزالة أي قشور وبقايا. &reg; &bull; قبل وضع دايڤوبيت<br />على وجهك. تقسيم منطقة الشعر قد يساعد قبل &reg; للتأكد من عدم تسرب دايڤوبيت<br />على المنطقة المصابة بأطراف أصابعك، &reg; ضع دايڤوبيت .&reg; استعمال دايڤوبيت<br />وافرك بلطف.<br /><strong>لا ضرورة لغسل شعرك قبل استعمال دايڤوبيت&reg;.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="358" height="505" vspace="0" hspace="0" border="0" style="width:358px;height:505px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا لزم الأمر، كرر الخطوات من 4 إلى 6 مرة أو مرتين.</strong><br /><u>مدة العلاج</u><br />&bull; استعمل الهلام مرة واحدة في اليوم. وقد يكون من الأفضل استخدامها في المساء<br />&bull; فترة العلاج الأولية الاعتيادية تستغرق 4 أسابيع لعلاج فروة الرأس و 8 أسابيع<br />لعلاج المناطق الأخرى<br />&bull; قد يتخذ طبيبك قراراً بشأن فترة علاج مختلفة<br />&bull; قد يقرر الطبيب تكرار العلاج<br />&bull; لا تستعمل أكثر من 15 جراماً في اليوم الواحد.<br />إذا كنت تستعمل أدوية أخرى تحتوي على كالسيبوتريول، فيجب أن لا تتجاوز كمية<br />الكالسيبوتريول 15 جراماً في اليوم والمنطقة المعالجة يجب أن لا تتجاوز 30 % من<br />اجمالي سطح الجسم.<br /><strong>ماذا ينبغي أن أتوقع عند استعمال دايڤوبيت&reg;؟</strong><br />يلاحظ معظم المرضى نتائج واضحة بعد مضي أسبوعين، حتى لو لم يتم التخلص من<br />الصدفية في تلك المرحلة.<br />إذا استعملت كمية أكثر من اللازم من دايڤوبيت&reg;&nbsp;يجب عليك:<br />استشارة الطبيب إذا كنت قد استخدمت أكثر من 15 جراماً في اليوم.<br />الإفراط في استعمال دايڤوبيت&reg; لفترة طويلة قد يسبب أيضاً مشكلة مع مستويات<br />الكالسيوم في الدم، والذي يعود إلى حاله الطبيعي بعد وقف العلاج.<br />قد يحتاج طبيبك إلى أخذ عينات من الدم للتأكد من أن استعمال الهلام بكثرة لم يتسبب<br />في مشكلة مع مستوي الكالسيوم في دمك.<br />كما قد يتسبب الاستخدام المفرط لفترات طويلة في توقف الغدد الكظرية عن العمل<br />بشكل صحيح (توجد الغدد الكظرية بالقرب من الكليتين وتنتج هرمونات).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا نسيت استعمال دايڤوبيت&reg;<br />لا تستعمل جرعة مضاعفة لتعويض الجرعة المنسية.<br />في حال التوقف عن استعمال دايڤوبيت&reg;<br />ينبغي التوقف عن استعمال دايڤوبيت&reg; حينما يشير طبيبك بذلك. قد تستدعي&nbsp;<br />الضرورة التوقف عن استعمال الدواء تدريجياً، وخاصة إذا كنت قد استعملته لفترة<br />طويلة.<br />إذا كانت لديك أية أسئلة إضافية حول استخدامات هذا الدواء، فيمكنك استشارة الطبيب<br />أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يتسبب هذا الدواء، مثل جميع الأدوية، في حدوث آثار جانبية، لكن ليس<br />بالضرورة أن يُصاب بها جميع الأشخاص.<br /><u>الآثار الجانبية الخطيرة</u><br />أبلغ الطبيب / الممرضة فوراً أو في أقرب وقت ممكن في حال حدوث ما يلي. قد<br />تضطر إلى التوقف عن العلاج.<br />حدثت الآثار الجانبية الخطيرة التالية جراء استعمال دايڤوبيت&reg;:<br />آثار غير شائعة (قد تؤثر على شخص واحد بحد أقصى من كل 100 شخص):<br />&bull; تفاقم مرض الصدفية. في هذه الحالة أخبر طبيبك بأقرب وقت ممكن.<br />ومن المعروف أن بعض الآثار الجانبية الخطيرة تكون بسبب بيتاميثازون )ستيرويد<br />يجب أن تخبر طبيبك في أقرب وقت ممكن .&reg; قوي(، أحد المكونات في دايڤوبيت<br />في حال حدوث أي من الآثار الجانبية الخطيرة. من المرجح أن تحدث هذه الآثار<br />الجانبية بعد استعمال طويل الأجل، أو استعماله تحت ضمادات مغلفة )كأن تستخدمه<br />على الفخذين أو تحت الإبطين أو تحت الثديين(، أو إذا استخدمته على مناطق كبيرة<br />من الجلد.<br />تتضمن الآثار الجانبية ما يلي:<br />&bull; قد تتوقف الغدد الكظرية عن العمل بشكل سليم. والأعراض تشمل التعب<br />والاكتئاب والقلق.<br />&bull; إعتام عدسة العين )تشمل الأعراض الرؤية الغائمة والضبابية، وصعوبة الرؤية في<br />الليل والحساسية للضوء( أو زيادة في الضغط داخل العين )تشمل الأعراض ألم في<br />العين، احمرار العين، انخفاض الرؤية أو الرؤية الضبابية(<br />&bull; التهابات (بسبب النظام المناعي الذي يكافح الإصابات، مما قد يعيق أو<br />يضعف وظيفته)<br />&bull; الصداف البثري )منطقة حمراء مع بثور صفراء تظهر عادة على اليدين أو<br />إذا لاحظت هذا، وأخبر طبيبك في أقرب &reg; القدمين(. توقف عن استعمال دايڤوبيت<br />وقت ممكن.<br />&bull; التأثير على السيطرة الأيضية لداء السكري (قد تواجهك تقلبات في مستويات<br />جلوكوز الدم إذا كنت مصاباً بداء السكري).<br />آثار جانبية خطيرة معروفة سببها الكالسيبوتريول:<br />&bull; ردود فعل تحسسية مع تورم في الوجه أو أجزاء أخرى من الجسم مثل اليدين أو<br />القدمين. وقد يحدث تورم في الفم/الحلق وصعوبة في التنفس. توقف عن تناول<br />إذا تعرضت لردود فعل الحساسية و<strong>أخبر طبيبك على الفور أو راجع &reg; دايڤوبيت<br />قسم الإصابات في أقرب مستشفى</strong><br />&bull; قد تزيد المعالجة بهذا الهلام من مستوى الكالسيوم في الدم أو البول )عادة عند<br />استعمال الكثير من الهلام( وأعراض زيادة الكالسيوم في الدم تكون آلام العظام،<br />الإمساك، ضعف الشهية والغثين والقيء. هذه الأعراض يمكن أن تكون خطيرة،<br /><strong>ولذلك يجب عليك الاتصال بطبيبك على الفور.</strong> ومع ذلك، عند توقف العلاج، تعود<br />المستويات إلى طبيعتها.<br /><u>آثار جانبية أقل خطورة</u><br />.&reg; تم الإبلاغ عن الآثار الجانبية التالية الأقل خطورة لدايڤوبيت<br />آثار جانبية شائعة (قد تؤثر على شخص واحد على الأكثر من بين كل 10 أشخاص):<br />&bull; حكّة.<br />آثار غير شائعة (قد تؤثر على شخص واحد بحد أقصى من كل 100 شخص):<br />&bull; تهيج العين<br />&bull; الإحساس بالحرقان في الجلد<br />&bull; ألم أو تهيج الجلد<br />&bull; التهاب أو تورم في جذور الشعر (التهاب الجريبات)<br />&bull; الطفح الجلدي مع التهاب الجيد (أكزيما)<br />&bull; احمرار في الجلد بسبب اتساع الأوعية الدموية الصغيرة (حمامي)<br />&bull; حب الشباب )البثور(<br />&bull; جفاف البشرة<br />&bull; الطفح الجلدي<br />&bull; الطفح البثري<br />&bull; التهاب الجلد.<br />آثار نادرة (قد تؤثر على شخص واحد بحد أقصى من كل 1000 شخص):<br />&bull; تفاعلات الحساسية<br />&bull; تجاعيد البشرة<br />&bull; تقشر الجلد<br />&bull; التأثير الانتكاسي: تفاقم الأعراض/الصدفية بعد انتهاء العلاج.<br />التكرار غير معروف (لا يمكن تقدير التكرار من البيانات المتاحة):<br />&bull; قد يتغير لون الشعر الأبيض أو الرمادي إلى اللون الأصفر في مكان استخدام<br />الدواء على فروة الرأس.<br />&bull; زغللة في البصر<br />تشمل الآثار الجانبية الأقل خطورة الناتجة عن استخدام بيتاميثازون، خاصةً لفترة<br />طويلة، ما يلي. وينبغي عليك أن تخطر الطبيب أو الممرضة في أقرب وقت ممكن<br />إذا لاحظت أي من هذه الأعراض:<br />&bull; ترقق الجلد.<br />&bull; ظهور الأوردة السطحية أو تجاعيد البشرة<br />&bull; تغيرات في نمو الشعر<br />&bull; طفح جلدي أحمر حول الفم (التهاب الجلد المحيط بالفم)<br />&bull; طفح جلدي مصحوب بالتهاب أو تورم (التهاب الجلد التماسي التحسسي)<br />&bull; نتوءات ذهبية اللون مليئة بالهلام )ميليا غروانية(<br />&bull; تفتُّح لون البشرة (فقدان التصبغ)<br />&bull; التهاب أو تورم جذر الشعر )التهاب الجريبات(.<br />تشمل الآثار الجانبية الأقل خطورة التي يسببها الكالسيبوتريول ما يلي:<br />&bull; جفاف البشرة<br />&bull; حساسية الجلد للضوء، مما يؤدي إلى طفح جلدي<br />&bull; الإكزيما<br />&bull; حكةّ<br />&bull; تهيُّج البشرة<br />&bull; حرقان ولسع<br />&bull; احمرار في الجلد بسبب اتساع الأوعية الدموية الصغيرة (حمامي)<br />&bull; الطفح الجلدي<br />&bull; الطفح الجلدي مع التهاب الجيد (أكزيما)<br />&bull; تفاقم مرض الصدفية.<br /><strong>الإبلاغ عن الآثار الجانبية</strong><br />يجب استشارة الطبيب أو الصيدلي أو الممرضة إذا تعرّضت لأي من الآثار الجانبية.<br />وهذا يتضمن أي آثار جانبية محتملة غير واردة في هذه النشرة.<br />فمن خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في تقديم المزيد من المعلومات<br />حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يُحفظ الدواء بعيدًا عن مرأى الأطفال ومتناول أيديهم<br />&bull; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العبوة بعد كلمة<br />يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور .&quot;EXP&quot;<br />&bull; لا يوضع في الثلاجة. احفظ العبوة داخل العبوة الكرتونية لحمايتها من الضوء<br />&bull; تخلّص من العبوة والهلام المتبقي بعد 3 أشهر من فتحها.<br />لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو المخلفات المنزلية.<br />استشر الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد<br />تستعملها. فهذه الإجراءات من شأنها المساعدة في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المواد الفعَّالة:<br />كالسيبوتريول وبيتاميثازون.<br />يحتوي كل جرام من الهلام على 50 ميكروجرام من الكالسيبوتريول<br />(مثل مونوهيدرات) و 0.5 ملجم من البيتاميثازون (مثل ديبروبيونات).<br />المكوّنات الأخرى هي:<br />&bull; البارافين، سائل<br />&bull; بولي أوكسي بروبالين ستيرل اثير<br />&bull; زيت الخروع، مهدرج<br />&bull; بوتيل هيدروكسي تولوين (E321)<br />ألفا-توكوفيرول راسيمي بالكامل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دايڤوبيت &reg; هو هلام صافي تقريباً، عديم اللون يميل إلى الأبيض قليلاً مُعبّأ في عبوات<br />البولي إثيلين عالي الكثافة مع فوهة بولي إيثيلين منخفضة الكثافة وغطاء لولبي من<br />البولي إيثيلين عالي الكثافة يتم وضع هذه العبوات في علب كرتونية.<br />أحجام العبوات: 30 جم و 60 جم. قد لا يتم تسويق جميع الأحجام.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">صاحب رخصة التسويق:<br />LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark<br />الشركة المصنعة:<br />LEO Laboratories Ltd., 285 Cashel Road, Crumlin, Dublin 12, Ireland</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يونيو 2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Daivobet 50 micrograms/0.5 mg/g gel 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One gram of gel contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).

Excipient with known effect
Butylhydroxytoluene (E321) 160 micrograms/g gel For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gel.
An almost clear, colourless to slightly off-white gel.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Topical treatment of scalp psoriasis in adults. Topical treatment of mild to moderate &ldquo;non-scalp&rdquo; plaque</p><p>psoriasis vulgaris in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>Daivobet gel should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for &ldquo;non-scalp&rdquo; areas. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision.</p><p>&nbsp;</p><p>When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g. The body surface area treated with calcipotriol containing medicinal products should not exceed 30% (see section 4.4).</p><p>&nbsp;</p><p><em>If used on the scalp</em></p><p>All the affected scalp areas may be treated with Daivobet gel. Usually an amount between 1 g and 4 g per day is sufficient for treatment of the scalp (4 g corresponds to one teaspoon).</p><p>&nbsp;</p><p><u>Special populations</u></p><p><em>Renal and hepatic impairment</em></p><p>The safety and efficacy of Daivobet gel in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The safety and efficacy of Daivobet gel in children below 18 years have not been established. Currently available data in children aged 12 to 17 years are described in section 4.8 and 5.1, but no recommendation on a posology can be made.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Daivobet gel should not be applied directly to the face or eyes. In order to achieve optimal effect, it is not recommended to take a shower or bath, or to wash the hair in case of scalp application, immediately after application of Daivobet gel. Daivobet gel should remain on the skin during the night or during the day.</p><p>&nbsp;</p><p><em>When using the Applicator</em></p><p>Prior to the first use of the Applicator the cartridge and the applicator head must be assembled. After priming, each full actuation delivers 0.05 g of Daivobet gel.</p><p>Daivobet gel is applied to the affected area by using the Applicator.</p><p>The hands should be washed after use if Daivobet gel gets on the fingers.</p><p>Daivobet gel Applicator is accompanied by the package leaflet with detailed instructions for use.</p><p>&nbsp;</p><p><em>When using the bottle</em></p><p>The bottle should be shaken before use and Daivobet gel applied to the affected area. The hands should be washed after use.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. Daivobet is contraindicated in erythrodermic, exfoliative and pustular psoriasis.
Due to the content of calcipotriol, Daivobet is contraindicated in patients with known disorders of calcium metabolism (see section 4.4).

Due to the content of corticosteroid, Daivobet is contraindicated in the following conditions: Viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds (see section 4.4).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effects on endocrine system</u></p><p>Daivobet gel contains a potent group III steroid and concurrent treatment with other steroids must be avoided. Adverse reactions found in connection with systemic corticosteroid treatment, such as adrenocortical suppression or impact on the metabolic control of diabetes mellitus may occur also during topical corticosteroid treatment due to systemic absorption.</p><p>&nbsp;</p><p>Application under occlusive dressings should be avoided since it increases the systemic absorption of corticosteroids. Application on large areas of damaged skin, or on mucous membranes or in skin folds should be avoided since it increases the systemic absorption of corticosteroids (see section 4.8).</p><p>&nbsp;</p><p>In a study in patients with both extensive scalp and extensive body psoriasis using a combination of high doses of Daivobet gel (scalp application) and high doses of Daivobet ointment (body application), 5 of 32 patients showed a borderline decrease in cortisol response to adrenocorticotropic hormone (ACTH) challenge after 4 weeks of treatment (see section 5.1).</p><p>&nbsp;</p><p><u>Visual disturbance</u></p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for a referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.</p><p>&nbsp;</p><p><u>Effects on calcium metabolism</u></p><p>Due to the content of calcipotriol, hypercalcaemia may occur if the maximum daily dose (15 g) is exceeded. Serum calcium is normalised when treatment is discontinued. The risk of hypercalcaemia is minimal when the recommendations relevant to calcipotriol are followed. Treatment of more than 30% of the body surface should be avoided (see section 4.2).</p><p>&nbsp;</p><p><u>Local adverse reactions</u></p><p>Daivobet contains a potent group III-steroid and concurrent treatment with other steroids on the same treatment area must be avoided.</p><p>Skin of the face and genitals are very sensitive to corticosteroids. The medicinal product should not be used in these areas.</p><p>The patient must be instructed in correct use of the medicinal product to avoid application and accidental transfer to the face, mouth and eyes. Hands must be washed after each application to avoid accidental transfer to these areas.</p><p>&nbsp;</p><p><u>Concomitant skin infections</u></p><p>When lesions become secondarily infected, they should be treated with antimicrobiological therapy. However, if infection worsens, treatment with corticosteroids should be stopped (see section 4.3).</p><p>&nbsp;</p><p><u>Discontinuation of treatment</u></p><p>When treating psoriasis with topical corticosteroids, there may be a risk of generalised pustular psoriasis or of rebound effects when discontinuing treatment. Medical supervision should therefore continue in the post- treatment period.</p><p>&nbsp;</p><p><u>Long-term use</u></p><p>With long-term use there is an increased risk of local and systemic corticosteroid adverse reactions. The treatment should be discontinued in case of adverse reactions related to long-term use of corticosteroid (see section 4.8).</p><p>&nbsp;</p><p><u>Unevaluated use</u></p><p>There is no experience with the use of Daivobet in guttate psoriasis.</p><p>&nbsp;</p><p><u>Concurrent treatment and UV exposure</u></p><p>Daivobet ointment for body psoriasis lesions has been used in combination with Daivobet gel for scalp psoriasis lesions, but there is limited experience of combination of Daivobet with other topical anti-psoriatic products at the same treatment area, other anti-psoriatic medicinal products administered systemically or with phototherapy.</p><p>&nbsp;</p><p>During Daivobet treatment, physicians are recommended to advise patients to limit or avoid excessive exposure to either natural or artificial sunlight. Topical calcipotriol should be used with UVR only if the physician and patient consider that the potential benefits outweigh the potential risks (see section 5.3).</p><p><u>Adverse reactions to excipients</u></p><p>Daivobet gel contains butylhydroxytoluene (E321) as an excipient, which may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed with Daivobet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no adequate data from the use of Daivobet in pregnant women. Studies in animals with glucocorticoids have shown reproductive toxicity (see section 5.3), but a number of epidemiological studies (less than 300 pregnancy outcomes) have not revealed congenital anomalies among infants born to women treated with corticosteroids during pregnancy. The potential risk for humans is uncertain. Therefore, during pregnancy, Daivobet should only be used when the potential benefit justifies the potential risk.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Betamethasone passes into breast milk, but risk of an adverse effect on the infant seems unlikely with therapeutic doses. There are no data on the excretion of calcipotriol in breast milk. Caution should be exercised when prescribing Daivobet to women who breast-feed. The patient should be instructed not to use Daivobet on the breast when breast-feeding.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Studies in rats with oral doses of calcipotriol or betamethasone dipropionate demonstrated no impairment of male and female fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Daivobet has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The estimation of the frequency of adverse reactions is based on a pooled analysis of data from clinical studies including post-authorisation safety studies and spontaneous reporting.</p><p>The most frequently reported adverse reaction during treatment is pruritus.</p><p>&nbsp;</p><p>Adverse reactions are listed by MedDRA SOC and the individual adverse reactions are listed starting with the most frequently reported. Within each frequency grouping, adverse reactions are presented in the order of decreasing seriousness.</p><p>&nbsp;</p><p>Very common (&ge;1/10) Common (&ge;1/100 to &lt;1/10)</p><p>Uncommon (&ge;1/1,000 to &lt;1/100) Rare (&ge;1/10,000 to &lt;1/1,000) Very rare (&lt;1/10,000)</p><p>Not known (cannot be estimated from available data)</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p>Infections and infestations</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon &ge;1/1,000 to &lt;1/100</p></td><td style="vertical-align:top"><p>Skin infection*</p><p>Folliculitis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Immune system disorders</p></td></tr><tr><td style="vertical-align:top"><p>Rare &ge;1/10,000 to &lt;1/1,000</p></td><td style="vertical-align:top"><p>Hypersensitivity</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Eye disorders</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon &ge;1/1,000 to &lt;1/100</p></td><td style="vertical-align:top"><p>Eye irritation</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Vision, blurred**</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td></tr><tr><td style="vertical-align:top"><p>Common &ge;1/100 to &lt; 1/10</p></td><td style="vertical-align:top"><p>Pruritus</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon &ge;1/1,000 to &lt;1/100</p></td><td style="vertical-align:top"><p>Exacerbation of psoriasis Dermatitis</p><p>Erythema Rash*** Acne</p><p>Skin burning sensation Skin irritation</p><p>Dry skin</p></td></tr><tr><td style="vertical-align:top"><p>Rare &ge;1/10,000 to &lt;1/1,000</p></td><td style="vertical-align:top"><p>Skin striae</p><p>Skin exfoliation</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hair colour changes****</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>General disorders and administration site conditions</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon &ge;1/1,000 to &lt;1/100</p></td><td style="vertical-align:top"><p>Application site pain*****</p></td></tr><tr><td style="vertical-align:top"><p>Rare &ge;1/10,000 to &lt;1/1,000</p></td><td style="vertical-align:top"><p>Rebound effect</p></td></tr></tbody></table><p><br />&nbsp;</p><p>*Skin infections including bacterial, fungal and viral skin infections have been reported.</p><p>**See section 4.4.</p><p>***Various types of rash reactions such as rash erythematous and rash pustular have been reported.</p><p>****Transient discolouration of the hair at scalp application site, to a yellowish colour in white or grey hair, has been reported.</p><p>*****Application site burning is included in application site pain.</p><p>&nbsp;</p><p>The following adverse reactions are considered to be related to the pharmacological classes of calcipotriol and betamethasone, respectively:</p><p>&nbsp;</p><p><u>Calcipotriol</u></p><p>Adverse reactions include application site reactions, pruritus, skin irritation, burning and stinging sensation, dry skin, erythema, rash, dermatitis, eczema, psoriasis aggravated, photosensitivity and hypersensitivity reactions including very rare cases of angioedema and facial oedema.</p><p>&nbsp;</p><p>Systemic effects after topical use may appear very rarely causing hypercalcaemia or hypercalciuria (see section 4.4).</p><p>&nbsp;</p><p><u>Betamethasone (as dipropionate)</u></p><p>Local reactions can occur after topical use, especially during prolonged application, including skin atrophy, telangiectasia, striae, folliculitis, hypertrichosis, perioral dermatitis, allergic contact dermatitis, depigmentation and colloid milia.</p><p>When treating psoriasis with topical corticosteroids, there may be a risk of generalised pustular psoriasis. Systemic reactions due to topical use of corticosteroids are rare in adults, however, they can be severe.</p><p>Adrenocortical suppression, cataract, infections, impact on the metabolic control of diabetes mellitus and&nbsp;increase of intra-ocular pressure can occur, especially after long-term treatment. Systemic reactions occur more frequently when applied under occlusion (plastic, skin folds), when applied on large areas and during long-term treatment (see section 4.4).</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>No clinically relevant differences between the safety profiles in adult and adolescent populations have been observed.</p><p>A total of 216 adolescent subjects were treated in three open label clinical trials. See section 5.1 for further details regarding the trials.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use above the recommended dose may cause elevated serum calcium which subsides when treatment is discontinued. The symptoms of hypercalcemia include polyuria, constipation, muscle weakness, confusion and coma.</p><p>&nbsp;</p><p>Excessive prolonged use of topical corticosteroids may suppress the pituitary-adrenal functions, resulting in secondary adrenal insufficiency which is usually reversible. In such cases, symptomatic treatment is indicated.</p><p>&nbsp;</p><p>In case of chronic toxicity, the corticosteroid treatment must be discontinued gradually.</p><p>&nbsp;</p><p>It has been reported that due to misuse one patient with extensive erythrodermic psoriasis treated with 240 g of Daivobet ointment weekly (corresponding to a daily dose of approximately 34 g) for 5 months (maximum recommended dose 15 g daily) developed Cushing&rsquo;s syndrome during treatment and then pustular psoriasis after abruptly stopping treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antipsoriatics. Other antipsoriatics for topical use, Calcipotriol, combinations. ATC Code: D05AX52</p><p>&nbsp;</p><p>Calcipotriol is a vitamin D analogue. In vitro data suggest that calcipotriol induces differentiation and suppresses proliferation of keratinocytes. This is the proposed basis for its effect in psoriasis.</p><p>&nbsp;</p><p>Like other topical corticosteroids, betamethasone dipropionate has anti-inflammatory, antipruritic, vasoconstrictive and immunosuppresive properties, however, without curing the underlying condition. Through occlusion the effect can be enhanced due to increased penetration of the stratum corneum. The incidence of adverse events will increase because of this. In general, the mechanism of the anti-inflammatory activity of the topical steroids is unclear.</p><p>&nbsp;</p><p>Adrenal response to ACTH was determined by measuring serum cortisol levels in patients with both extensive scalp and body psoriasis, using up to 106 g per week combined Daivobet gel and Daivobet ointment. A borderline decrease in cortisol response at 30 minutes post ACTH challenge was seen in 5 of 32&nbsp;patients (15.6 %) after 4 weeks of treatment and in 2 of 11 patients (18.2 %) who continued treatment until 8 weeks. In all cases, the serum cortisol levels were normal at 60 minutes post ACTH challenge. There was no evidence of change of calcium metabolism observed in these patients. With regard to HPA suppression, therefore, this study shows some evidence that very high doses of Daivobet gel and ointment may have a weak effect on the HPA axis.</p><p>&nbsp;</p><p>The efficacy of once daily use of Daivobet gel was investigated in two randomised, double-blind, 8-week clinical studies including a total of more than 2,900 patients with scalp psoriasis of at least mild severity according to the Investigator&rsquo;s Global Assessment of disease severity (IGA). Comparators were betamethasone dipropionate in the gel vehicle, calcipotriol in the gel vehicle and (in one of the studies) the gel vehicle alone, all used once daily. Results for the primary response criterion (absent or very mild disease according to the IGA at week 8) showed that Daivobet gel was statistically significantly more effective than the comparators. Results for speed of onset based on similar data at week 2 also showed Daivobet gel to be statistically significantly more effective than the comparators.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>% of patients with absent or very</p><p>mild disease</p></td><td style="vertical-align:top"><p>Daivobet gel (n=1,108)</p></td><td style="vertical-align:top"><p>Betamethasone dipropionate</p><p>(n=1,118)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Calcipotriol (n=558)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Gel vehicle (n=136)</p></td></tr><tr><td style="vertical-align:top"><p>week 2</p></td><td style="vertical-align:top"><p>53.2 %</p></td><td style="vertical-align:top"><p>42.8 %<sup>1</sup></p></td><td style="vertical-align:top"><p>17.2 %<sup>1</sup></p></td><td style="vertical-align:top"><p>11.8 %<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>week 8</p></td><td style="vertical-align:top"><p>69.8 %</p></td><td style="vertical-align:top"><p>62.5 %<sup>1</sup></p></td><td style="vertical-align:top"><p>40.1 %<sup>1</sup></p></td><td style="vertical-align:top"><p>22.8 %<sup>1</sup></p></td></tr></tbody></table><p><sup>1</sup> Statistically significantly less effective than Daivobet gel (P&lt;0.001)</p><p>&nbsp;</p><p>The efficacy of once daily use of Daivobet gel on non-scalp regions of the body was investigated in a randomised, double-blind, 8-week clinical study including 296 patients with psoriasis vulgaris of mild or moderate severity according to the IGA. Comparators were betamethasone dipropionate in the gel vehicle, calcipotriol in the gel vehicle and the gel vehicle alone, all used once daily. Primary response criteria were controlled disease according to the IGA at week 4 and week 8. Controlled disease was defined as &lsquo;clear&rsquo; or &lsquo;minimal disease&rsquo; for patients with moderate disease at baseline or &lsquo;clear&rsquo; for patients with mild disease at baseline. The percentage change in Psoriasis Severity and Area index (PASI) from baseline to week 4 and week 8 were secondary response criteria.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>% of patients with controlled disease</p></td><td style="vertical-align:top"><p>Daivobet gel (n=126)</p></td><td style="vertical-align:top"><p>Betamethasone dipropionate</p><p>(n=68)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Calcipotriol (n=67)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Gel vehicle (n=35)</p></td></tr><tr><td style="vertical-align:top"><p>week 4</p></td><td style="vertical-align:top"><p>20.6 %</p></td><td style="vertical-align:top"><p>10.3 %<sup>1</sup></p></td><td style="vertical-align:top"><p>4.5 %<sup>1</sup></p></td><td style="vertical-align:top"><p>2.9 %<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>week 8</p></td><td style="vertical-align:top"><p>31.7 %</p></td><td style="vertical-align:top"><p>19.1 %<sup>1</sup></p></td><td style="vertical-align:top"><p>13.4 %<sup>1</sup></p></td><td style="vertical-align:top"><p>0.0 %<sup>1</sup></p></td></tr></tbody></table><p><sup>1</sup> Statistically significantly less effective than Daivobet gel (P&lt;0.05)</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Mean percentage</p><p>reduction in PASI (SD)</p></td><td style="vertical-align:top"><p>Daivobet gel (n=126)</p></td><td style="vertical-align:top"><p>Betamethasone</p><p>dipropionate (n=68)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Calcipotriol (n=67)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Gel vehicle (n=35)</p></td></tr><tr><td style="vertical-align:top"><p>week 4</p></td><td style="vertical-align:top"><p>50.2 (32.7)</p></td><td style="vertical-align:top"><p>40.8 (33.3)<sup>1</sup></p></td><td style="vertical-align:top"><p>32.1 (23.6)<sup>1</sup></p></td><td style="vertical-align:top"><p>17.0 (31.8)<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>week 8</p></td><td style="vertical-align:top"><p>58.8 (32.4)</p></td><td style="vertical-align:top"><p>51.8 (35.0)</p></td><td style="vertical-align:top"><p>40.8 (31.9)<sup>1</sup></p></td><td style="vertical-align:top"><p>11.1 (29.5)<sup>1</sup></p></td></tr></tbody></table><p><sup>1</sup> Statistically significantly less effective than Daivobet gel (P&lt;0.05)</p><p>&nbsp;</p><p>Another randomised, investigator-blinded clinical study including 312 patients with scalp psoriasis of at least moderate severity according to the IGA investigated use of Daivobet gel once daily compared with Daivonex Scalp solution twice daily for up to 8 weeks. Results for the primary response criterion (absent or very mild&nbsp;disease according to the IGA at week 8) showed that Daivobet gel was statistically significantly more effective than Daivonex Scalp solution.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>% of patients with absent or very</p><p>mild disease</p></td><td style="vertical-align:top"><p>Daivobet gel (n=207)</p></td><td style="vertical-align:top"><p>Daivonex Scalp solution</p><p>(n=105)</p></td></tr><tr><td style="vertical-align:top"><p>week 8</p></td><td style="vertical-align:top"><p>68.6 %</p></td><td style="vertical-align:top"><p>31.4 %<sup>1</sup></p></td></tr></tbody></table><p><sup>1</sup> Statistically significantly less effective than Daivobet gel (P&lt;0.001)</p><p>&nbsp;</p><p>A randomised, double-blind long-term clinical study including 873 patients with scalp psoriasis of at least moderate severity (according to the IGA) investigated the use of Daivobet gel compared with calcipotriol in the gel vehicle. Both treatments were applied once daily, intermittently as required, for up to 52 weeks.</p><p>Adverse events possibly related to long-term use of corticosteroids on the scalp, were identified by an independent, blinded panel of dermatologists. There was no difference in the percentages of patients experiencing such adverse events between the treatment groups (2.6 % in the Daivobet gel group and 3.0 % in the calcipotriol group; P=0.73). No cases of skin atrophy were reported.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p><em>Scalp</em></p><p>Effects on calcium metabolism were investigated in two uncontrolled open 8-week trials including in total 109 adolescents aged 12-17 years with scalp psoriasis who used up to 69 g per week of Daivobet gel. No cases of hypercalcaemia and no clinically relevant changes in urinary calcium were reported. The adrenal response to ACTH challenge was measured in 30 patients; one patient showed a decrease in cortisol response to ACTH challenge after 4 weeks of treatment, which was mild, without clinical manifestations, and reversible.</p><p>&nbsp;</p><p><em>Scalp and body</em></p><p>Effects on calcium metabolism was investigated in one uncontrolled open 8-week trial in 107 adolescents aged 12-17 years with scalp and body psoriasis who used up to 114.2 g per week of Daivobet gel. No cases of hypercalcaemia and no clinically relevant changes in urinary calcium were reported. The adrenal response to ACTH challenge was measured in 31 patients; five patients showed a decrease in cortisol response to ACTH challenge where 2 of the 5 patients showed only borderline decreases. Four of the patients showed decrease after 4 weeks of treatment and 2 showed decrease after 8 weeks including 1 patient showing a decrease at both periods. These events were mild, without clinical manifestations, and reversible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The systemic exposure to calcipotriol and betamethasone dipropionate from topically applied Daivobet gel is comparable to Daivobet ointment in rats and minipigs. Clinical studies with radiolabelled ointment indicate that the systemic absorption of calcipotriol and betamethasone from Daivobet ointment formulation is less than 1 % of the dose (2.5 g) when applied to normal skin (625 cm<sup>2</sup>) for 12 hours. Application to psoriasis plaques and under occlusive dressings may increase the absorption of topical corticosteroids. Absorption through damaged skin is approx. 24 %.</p><p>&nbsp;</p><p>Following systemic exposure, both active ingredients &ndash; calcipotriol and betamethasone dipropionate &ndash; are rapidly and extensively metabolised. Protein binding is approx. 64 %. Plasma elimination half-life after intravenous application is 5-6 hours. Due to the formation of a depot in the skin elimination after dermal application is in order of days. Betamethasone is metabolised especially in the liver, but also in the kidneys to glucuronide and sulfate esters. The main route of excretion of calcipotriol is via faeces (rats and minipigs) and for betamethasone dipropionate it is via urine (rats and mice). In rats, tissue distribution studies with&nbsp;radiolabelled calcipotriol and betamethasone dipropionate, respectively, showed that the kidney and liver had the highest level of radioactivity.</p><p>&nbsp;</p><p>Calcipotriol and betamethasone dipropionate were below the lower limit of quantification in all blood samples of 34 patients treated for 4 or 8 weeks with both Daivobet gel and Daivobet ointment for extensive psoriasis involving the body and scalp. One metabolite of calcipotriol and one metabolite of betamethasone dipropionate were quantifiable in some of the patients.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Studies of corticosteroids in animals have shown reproductive toxicity (cleft palate, skeletal malformations). In reproduction toxicity studies with long-term oral administration of corticosteroids to rats, prolonged gestation and prolonged and difficult labour were detected. Moreover, reduction in offspring survival, body weight and body weight gain was observed. There was no impairment of fertility. The relevance for humans is unknown.</p><p>&nbsp;</p><p>A dermal carcinogenicity study with calcipotriol in mice and an oral carcinogenicity study in rats revealed no special risk to humans.</p><p>&nbsp;</p><p>Photo(co)carcinogenicity studies in mice suggest that calcipotriol may enhance the effect of UVR to induce skin tumours.</p><p>&nbsp;</p><p>A dermal carcinogenicity study in mice and an oral carcinogenicity study in rats revealed no special risk of betamethasone dipropionate to humans. No photocarcinogenicity study has been performed with betamethasone dipropionate.</p><p>&nbsp;</p><p>In local tolerability studies in rabbits, Daivobet gel caused mild to moderate skin irritation and a slight transient irritation of the eye.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paraffin, liquid Polyoxypropylene stearyl ether Castor oil, hydrogenated Butylhydroxytoluene (E321) All-rac-&alpha;-tocopherol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.

Bottle: After first opening: 6 months.

Applicator: After first opening: 6 months.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not refrigerate.</p><p>&nbsp;</p><p><em>Bottle: </em>Keep in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Bottles: </em>High-density polyethylene bottles with low-density polyethylene nozzle and a high-density polyethylene screw cap. The bottles are placed in cartons.</p><p>Pack sizes: 15 g, 30 g, 60 g, 80 g, 2 x 60 g, 2 x 80 g and 3 x 60 g.</p><p>&nbsp;</p><p><em>Applicator: </em>The Applicator consists of a polypropylene cartridge (with a high-density polyethylene plunger and screw cap), an applicator head (polypropylene outer casing, polyoxymethylene lever and thermoplastic elastomer nozzle) and polypropylene cover. The cartridge, applicator head and cover are assembled prior to use. The cartridge(s), applicator head(s) and cover(s) are placed in a carton.</p><p>Pack sizes: 60 g (equivalent to 68 ml) and 2 x 60 g (equivalent to 2 x 68 ml) Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LEO Pharma A/S Industriparken 55 DK-2750 Ballerup Denmark
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>